This announcement is a separate document:
诺诚健华：上海荣正企业咨询服务（集团）股份有限公司关于诺诚健华医药有限公司2024年科创板限制性股票激励计划首次授予事项之独立财务顾问报告
Nuochengjianhua: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the first grant of Nuochengjianhua Pharmaceutical Co., Ltd.\'s 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated